{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T14:50:11Z","timestamp":1697381411573},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1097\/01.jtn.0000337153.08464.0f","type":"journal-article","created":{"date-parts":[[2013,9,14]],"date-time":"2013-09-14T13:50:32Z","timestamp":1379166632000},"page":"118-122","source":"Crossref","is-referenced-by-count":5,"title":["Propofol Infusion Syndrome"],"prefix":"10.1097","volume":"15","author":[{"given":"Carol","family":"Rajda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darlene","family":"Dereczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patti","family":"Kunkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-9-20210129","doi-asserted-by":"crossref","first-page":"28S","DOI":"10.1592\/phco.2005.25.5_Part_2.28S","article-title":"Propofol: an immodulating agent.","volume":"25","author":"Marik","year":"2005","journal-title":"Pharmacotherapy"},{"key":"R2-9-20210129","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1017\/S0265021506001281","article-title":"The propofol infusion syndrome: the facts, their interpretation and implications for patient care.","volume":"23","author":"Ahlen","year":"2006","journal-title":"Eur J Anaesthesiol"},{"issue":"3","key":"R3-9-20210129","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/01.TA.0000159697.03562.D6","article-title":"Rare but dangerous adverse effects of propofol and thiopental in intensive care.","volume":"58","author":"Machata","year":"2005","journal-title":"J Trauma"},{"issue":"4","key":"R4-9-20210129","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/01.aco.0000236140.08228.f1","article-title":"Propofol infusion syndrome in anaesthesia and intensive care medicine.","volume":"19","author":"Fudickar","year":"2006","journal-title":"Curr Opin Anaesthesiol"},{"key":"R5-9-20210129","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1365-2044.2007.05055.x","article-title":"Propofol infusion syndrome.","volume":"62","author":"Kam","year":"2007","journal-title":"Anaesthesia"},{"issue":"5","key":"R6-9-20210129","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/00000542-200611000-00027","article-title":"Reports of death with use of propofol (Diprivan) for nonprocedural (long-term) sedation and literature review.","volume":"105","author":"Wysowski","year":"2006","journal-title":"Anesthesiology"},{"key":"R7-9-20210129","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3171\/jns.2001.95.6.1053","article-title":"Metabolic acidosis, rhabdomyolysis, and cardiovascular collapse after prolonged propofol infusion.","volume":"95","author":"Cannon","year":"2001","journal-title":"J Neurosurg"},{"issue":"2","key":"R8-9-20210129","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/TA.0b013e31809fe910","article-title":"Too much of a good thing? Tracing the history of the propofol infusion syndrome.","volume":"63","author":"Rosen","year":"2007","journal-title":"J Trauma"},{"issue":"1","key":"R9-9-20210129","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4037\/ajcc2007.16.1.82","article-title":"Propofol infusion syndrome: a case of increasing morbidity with traumatic brain injury.","volume":"16","author":"Sabsovich","year":"2007","journal-title":"Am J Crit Care"},{"key":"R10-9-20210129","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/clinchem\/46.4.577","article-title":"Propofol-associated rhabdomyolysis with cardiac involvement in adults: chemical and anatomic findings.","volume":"46","author":"Stelow","year":"2000","journal-title":"Clin Chem"},{"key":"R11-9-20210129","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/bmj.305.6854.613","article-title":"Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports.","volume":"305","author":"Parke","year":"1992","journal-title":"BMJ"},{"key":"R12-9-20210129","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3171\/jns.2001.95.6.0925","article-title":"Propofol-infusion syndrome.","volume":"95","author":"Kelly","year":"2001","journal-title":"J Neurosurg"},{"key":"R13-9-20210129","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(00)03547-9","article-title":"Long-term propofol infusion and cardiac failure in adult head-injured patients.","volume":"357","author":"Cremer","year":"2001","journal-title":"Lancet"},{"key":"R14-9-20210129","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00134-003-1905-x","article-title":"The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome.","volume":"29","author":"Vasile","year":"2003","journal-title":"Intensive Care Med"},{"issue":"9","key":"R15-9-20210129","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1097\/01.CCM.0000230238.72846.B3","article-title":"Survival of propofol infusion syndrome in a head-injured patient.","volume":"34","author":"Corbett","year":"2006","journal-title":"Crit Care Med"},{"key":"R16-9-20210129","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1460-9592.2004.01332.x","article-title":"Propofol infusion in children: when does an anesthetic tool become an intensive care liability?","volume":"14","author":"Wolf","year":"2004","journal-title":"Paediatr Anaesth"},{"issue":"9","key":"R20-9-20210129","first-page":"343","article-title":"Choice of sedation for critically ill patients: a rational approach.","volume":"2","author":"Brusco","year":"2002","journal-title":"Adv Stud Med"},{"issue":"2","key":"R21-9-20210129","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1592\/phco.28.2.250","article-title":"Propofol-related infusion syndrome in intensive care patients.","volume":"28","author":"Corbett","year":"2008","journal-title":"Pharmacotherapy"},{"key":"R22-9-20210129","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1093\/ajhp\/60.19.2007","article-title":"Evaluation of propofol infusion syndrome in pediatric intensive care.","volume":"60","author":"Okamoto","year":"2003","journal-title":"Am J Health Syst Pharm"},{"issue":"9","key":"R24-9-20210129","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1592\/phco.20.13.1120.35041","article-title":"Clinical significance of rare and benign side effects: propofol and green urine.","volume":"20","author":"Blakey","year":"2000","journal-title":"Pharmacotherapy"},{"key":"R25-9-20210129","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.2146\/ajhp060045","article-title":"Adverse-drug-event rates for high-cost and high-use drugs in the intensive care unit.","volume":"63","author":"Kane-Gill","year":"2006","journal-title":"Am J Health Syst Pharm"}],"container-title":["Journal of Trauma Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JTN.0000337153.08464.0f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T19:21:49Z","timestamp":1620933709000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043860-200807000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jtn.0000337153.08464.0f","relation":{},"ISSN":["1078-7496"],"issn-type":[{"value":"1078-7496","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}